The Institute for Clinical and Economic Review (ICER) has released a Draft Evidence Report evaluating the comparative clinical effectiveness and value of Novo Nordisks Wegovy (semaglutide) and Eli Lillys Zepbound (tirzepatide) for obesity management, including their impact on other obesity-related outcomes
Brand-name drugs are more expensive but offer higher safety assurances
If you are still experiencing nausea, diarrhea, or significant appetite changes from your most recent dose increase, do not compound those effects with another increase
30% of GLP-1 medications acquired via compounding pharmacies, Beckers Hospital Review, July 31, 2024
The retinol-RBP4 complex is then transported to the cell surface within the Golgi and secreted
Embarking on your healthcare journey has never been easier with the support of our telehealth professionals